Parkinson’s Disease Therapeutics Pipeline Program


This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.

Only open to industry and industry-academia collaborations.

More details

Website :